Stay updated on Neutron Radiation+Pembrolizumab in Advanced Urothelial Carcinoma Clinical Trial
Sign up to get notified when there's something new on the Neutron Radiation+Pembrolizumab in Advanced Urothelial Carcinoma Clinical Trial page.

Latest updates to the Neutron Radiation+Pembrolizumab in Advanced Urothelial Carcinoma Clinical Trial page
- CheckyesterdayChange DetectedA sitewide NIH notice announces a transition from the term “Artificial Intelligence” to “Super Intelligence” and links to transition updates and FAQs.SummaryDifference1%

- Check8 days agoChange DetectedThe footer now displays revision v3.7.2 instead of v3.7.1.SummaryDifference0.2%

- Check14 days agoChange DetectedThe site footer revision label changed from v3.7.0 to v3.7.1; the page continues to display a 403 error.SummaryDifference0.2%

- Check35 days agoChange DetectedThe study page now displays a 403 Forbidden error, indicating restricted access to the record, with the standard header and footer visible but no study details accessible.SummaryDifference18%

- Check56 days agoChange DetectedThe page now shows Revision: v3.6.6, replacing v3.6.5. This indicates a minor update to the page version without changing the study content.SummaryDifference0.1%

- Check77 days agoChange DetectedThe page received a software release update to v3.6.5 (replacing v3.6.4). This update does not change the study content or data presented on the page.SummaryDifference0.1%

Stay in the know with updates to Neutron Radiation+Pembrolizumab in Advanced Urothelial Carcinoma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Neutron Radiation+Pembrolizumab in Advanced Urothelial Carcinoma Clinical Trial page.